Tvac-001 New Antigen Reactivity T Cell Injection Solution

N/A

Report date: 2026/05/27 14:16:08

Base Information

Drug NameTvac-001 New Antigen Reactivity T Cell Injection Solution
Drug Alias NameTvac001新抗原反应性T细胞注射液Tvac001Tvac-001
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesGz Runsheng Cytomed Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGz Runsheng Cytomed Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A